AMTM vs CRL · rev $14.39B vs rev $2.00B
Amentum Holdings Inc. (AMTM) versus Charles River Laboratories (CRL) — a side-by-side from cached financials, not a winner call.
Amentum Holdings Inc. (AMTM) is a specialty business services company listed on US.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Latest reported AMTM revenue for 2025-10-03 was $14.39B. Net income was $66.0M. Revenue was up 71.6% from 2024-09-27 to 2025-10-03. AMTM currently screens at market cap $4.87B.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
AMTM currently screens at market cap $4.87B. CRL currently screens at market cap $7.78B.
Not investment advice. Open the AMTM and CRL stock pages for the full models.
Not investment advice.